Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation

Pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation

US Patent 10758552 · Granted Sep 1, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition containing nicotinic acid and/or nicotinamide for ben2021
Pharmaceutical composition containing nicotinic acid and/or nicotinamide for ben2021
Pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or 2019
Sgp130/Fc dimers2017
Sgp130/Fc dimers2017
sgp130/Fc dimers for treatment of inflammatory disease2015
sgp130/Fc dimers for treatment of inflammatory disease2015
sgp130/Fc dimers2014
sgp130/Fc dimers2014
Soluble GP130 muteins with improved binding activity2013
Optimized nucleotide sequences encoding sgp1302012
Optimized nucleotide sequences encoding sgp1302012